Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 45.06 USD -0.92% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Amphastar Pharmaceuticals Inc?
Write Note

Amphastar Pharmaceuticals Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amphastar Pharmaceuticals Inc
Accounts Receivables Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Accounts Receivables
$131.4m
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
22%
Johnson & Johnson
NYSE:JNJ
Accounts Receivables
$16.2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Accounts Receivables
$9.7B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
18%
Pfizer Inc
NYSE:PFE
Accounts Receivables
$11.4B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Accounts Receivables
$11.4B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Accounts Receivables
$10.3B
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
11%

See Also

What is Amphastar Pharmaceuticals Inc's Accounts Receivables?
Accounts Receivables
131.4m USD

Based on the financial report for Jun 30, 2024, Amphastar Pharmaceuticals Inc's Accounts Receivables amounts to 131.4m USD.

What is Amphastar Pharmaceuticals Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
22%

Over the last year, the Accounts Receivables growth was 26%. The average annual Accounts Receivables growth rates for Amphastar Pharmaceuticals Inc have been 25% over the past three years , 22% over the past five years , and 22% over the past ten years .

Back to Top